Infection and Immunity · 2008 · 122 citations · 32 references
Life SciencesImmunologyInfectious DiseasesAntibody EngineeringInnate ImmunityProtein EngineeringAntibacterial PharmacologyAntibody Specificity EngineeringAntibody-mediated ProtectionBacterial ImmunologyBacterial Secretion SystemsPulmonary InfectionsAntibacterial ImmunityAntibody Effector FunctionsAntibody-mediated Bacterial ProtectionBacterial ExotoxinsFab Antibody FragmentsFc Receptor-mediated Effector FunctionsNeutralizationToxin Secretion Systems
Pseudomonas aeruginosa is an opportunistic pathogen that can cause acute lung injury and mortality through the delivery of exotoxins by the type III secretion system (TTSS). PcrV is an important structural protein of the TTSS. An engineered human antibody Fab fragment that binds to the P. aeruginosa PcrV protein with high affinity has been identified and has potent in vitro neutralization activity against the TTSS. The instillation of a single dose of Fab into the lungs of mice provided protection against lethal pulmonary challenge of P. aeruginosa and led to a substantial reduction of viable bacterial counts in the lungs. These results demonstrate that blocking of the TTSS by a Fab lacking antibody Fc-mediated effector functions can be sufficient for the effective clearance of pulmonary P. aeruginosa infection.
32
Arup Roy‐Burman, Richard H. Savel, Sara Racine et al. · The Journal of Infectious Diseases · 2001 · 439 citations · Full text
Therapeutic antibody fragments with prolonged in vivo half-lives
Andrew P. Chapman, Pari Antoniw, Mariangela Spitali et al. · Nature Biotechnology · 1999 · 348 citations